Why I’m avoiding this outperforming FTSE 250 stock now

Another stonking set of results from this FTSE 250 (INDEXFTSE: MCX) company, but here’s why I’m wary of the stock.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Landscape products supplier Marshalls (LSE: MSLH) delivered another set of stonking half-year results this morning, which is the type of trading outcome we’ve become used to from the firm.

Double-digit percentage increases in annual earnings have been a feature of the financial record for at least six years, and the share price has responded accordingly. Over the past seven years, the stock is up more than 600% at today’s 618p.

Good figures

And today’s figures are good too. Revenue in the first half the year increased by 15% compared to the equivalent period last year, earnings per share went 15% higher, and net cash from operations before movements in working capital shot up by 36%. That looks like well-balanced growth to me. The directors applied their own seal of approval by slapping 18% on the interim dividend.

Looking forward, the company said trading since 30 June “has remained strong”. The directors recently declared a new five-year strategy with the objective of delivering “sustainable growth”. Chief executive Martyn Coffey said in the report the strategy is underpinned by “strong market positions, focused investment plans and an established brand”.  The directors are increasingly confident” that Marshalls will at least achieve its expectations for the full 2019 year.

City analysts following the firm have pencilled mid-to-high single-digit advances in earnings for 2019 and 2020. But that’s anticipating a slowdown in growth because the advances of the past few years have been well into double-digits. However, my view is that Marshalls’ operations had been recovering from a cyclical low following the post-credit-crunch recession last decade, which would have accounted for much of the advance in earnings we’ve seen over the past few years.

But on top of that, the firm has been expanding organically and via acquisitions. Research & development and new product launches have played their part in the firm’s operational progress. There’s also been a keen management focus on execution and cost control.

A rich valuation

Yet I think the spectre of the cyclicality of the sector hangs over the stock now. With earnings growth slowing, could we be getting close to peak earnings for Marshall’s in the current economic cycle? Maybe. But I see little evidence of caution in the valuation. Indeed, with the shares at 618p the forward-looking earnings multiple for 2020 sits just above 20 and the anticipated dividend yield is a little over 2.5%.

Ignoring the potential cyclicality of operations for a moment, I think a valuation that high is rich even for an out-and-out growth firm that is expecting to increase its earnings by single-digit annual percentages ahead. It seems clear to me that a big part of the stock’s meteoric rise has been because of a valuation uprating.

So I’m wary of the stock because I see huge potential for the valuation to adjust down again. But I was cautious for similar reasons 16 months ago, and the share price has put on almost 50% since then! Nevertheless, I’m avoiding Marshalls now.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Now 70p, is £1 the next stop for the Vodafone share price?

The Vodafone share price is back to 70p, but it's a long way short of the 97p it hit in…

Read more »

Concept of two young professional men looking at a screen in a technological data centre
Investing Articles

If I’d put £5,000 in Nvidia stock at the start of 2024, here’s what I’d have now

Nvidia stock was a massive winner in 2023 as the AI chipmaker’s profits surged across the year. How has it…

Read more »

Light bulb with growing tree.
Investing Articles

3 top investment trusts that ‘green’ up my Stocks and Shares ISA

I’ll be buying more of these investment trusts for my Stocks and Shares ISA given the sustainable and stable returns…

Read more »

Investing Articles

8.6% or 7.2%? Does the Legal & General or Aviva dividend look better?

The Aviva dividend tempts our writer. But so does the payout from Legal & General. Here he explains why he'd…

Read more »

a couple embrace in front of their new home
Investing Articles

Are Persimmon shares a bargain hiding in plain sight?

Persimmon shares have struggled in 2024, so far. But today's trading update suggests sentiment in the housing market's already improving.

Read more »

Market Movers

Here’s why the Unilever share price is soaring after Q1 earnings

Stephen Wright isn’t surprised to see the Unilever share price rising as the company’s Q1 results show it’s executing on…

Read more »

Investing Articles

Barclays’ share price jumps 5% on Q1 news. Will it soon be too late to buy?

The Barclays share price has been having a great time this year, as a solid Q1 gives it another boost.…

Read more »

Young black colleagues high-fiving each other at work
Investing Articles

The AstraZeneca share price lifts 5% on a top-and-bottom earnings beat

The AstraZeneca share price reached £120 today and helped push the FTSE 100 higher. Would I still buy this flying…

Read more »